Novo Nordisk (NYSE: NVO) announced plans to cut the list prices of these drugs by up to 50% in the U.S. starting in 2027, on Tuesday.

Eli Lilly on Monday launched a new form of its blockbuster obesity drug, Zepbound, that offers a month's worth of doses in a ...

Consolidation of four doses may lower secondary packaging complexity and improve fill-finish throughput predictability, although Lilly has not quantified manufacturing efficiency gains. Multi-dose use ...

Lilly’s momentum isn’t just about its successful clinical results, though. It’s also about the company’s constant iteration ...

Eli Lilly said on Monday it received the U.S. Food and Drug Administration's approval to launch a four-dose KwikPen for its weight-loss drug Zepbound, delivering a full month of the treatment in a ...

Eli Lilly trades near historical P/E means of ~30x with a 3Y PEG of 1.13x, offering attractive long-term upside potential. Click here to read why LLY is a Buy.

Pharmaceutical giant Eli Lilly and Company (NYSE:LLY)’s shares are up by 23.5% over the past year and down by more than 1% ...

We may receive a commission on purchases made from links. The Duramax 6.6L V8 diesel engine was a huge moment for General Motors' heavy-duty trucks. Even though it looks pretty similar on the outside ...

Novo Nordisk is rated hold due to weak guidance, declining margins, and falling market share despite a low P/E valuation. NVO's 2026 outlook projects a -5% to -13% sales and operating profit decline, ...

The stock market is divided, with the Nasdaq and S&P 500 breaking support but many sectors thriving. Google and Amazon AI spending stunned. Bitcoin plunged.

Building something in Minecraft can take quite some time. Sometimes, one's block choice doesn't end up being ideal, and players need to swap their blocks for others. This usually takes time while ...

General Motors has released an updated fix for a fuel injector flow rate issue affecting certain units of the Chevy Trax crossover, revising an earlier Service Update for the issue with a more ...